DURLAZA Drug Patent Profile
✉ Email this page to a colleague
When do Durlaza patents expire, and what generic alternatives are available?
Durlaza is a drug marketed by Hesp and is included in one NDA.
The generic ingredient in DURLAZA is aspirin. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the aspirin profile page.
Summary for DURLAZA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,979 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in DURLAZA? | DURLAZA excipients list |
| DailyMed Link: | DURLAZA at DailyMed |
Recent Clinical Trials for DURLAZA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| United States Department of Defense | Phase 2 |
| Massachusetts General Hospital | Phase 2 |
| Massachusetts Eye and Ear Infirmary | Phase 2 |
US Patents and Regulatory Information for DURLAZA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hesp | DURLAZA | aspirin | CAPSULE, EXTENDED RELEASE;ORAL | 200671-001 | Sep 4, 2015 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
